Timo Joensuu

Timo Joensuu (born 27 February 1959 in Nokia, Finland) is a Finnish oncologist, associate professor of clinical oncology in University of Helsinki, researcher of new cancer treatments and developer of an internationally new hospital concept.

He has also been medical advisor for AstraZeneca and for Helsinki Consulting Group and World Bank in Serbia year 2004.

[2] Dr Joensuu has led several clinical trials and published articles on oncolytic adenovirus therapy, radiotherapy, chemoradiotherapy and prostate cancer.

[4] At Docrates Cancer Center Dr Joensuu was especially devoted to the development of target radiotherapy, research and clinical trials.

Dr Joensuus's vision is a fast track path from diagnosis to treatment, founded on the belief that cancer care can be carried out different way compared to traditional models.